Skip to main content
TipRanks
Go Ultimate75% OFF

Entrada Therapeutics Inc (TRDA) Income Statement

164 Followers

Entrada Therapeutics Inc Income Statement

Last quarter (Q3 2026), Entrada Therapeutics Inc's total revenue was $905.00K, a decrease of 43.93% from the same quarter last year. In Q3, Entrada Therapeutics Inc's net income was $-39.74M. See Entrada Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 25.42M$ 210.78M$ 129.01M$ 0.00$ 0.00
$ 21.32M$ 210.78M$ 129.01M$ 0.00$ 0.00
$ 177.32M$ 163.77M$ 132.18M$ 97.25M$ 51.13M
Depreciation and Amortization$ 4.10M$ 3.77M$ 2.84M$ 1.90M$ 1.12M
$ -138.73M$ 70.26M$ 14.90M$ -90.09M$ -50.04M
$ -156.00M$ 47.01M$ -3.16M$ -97.25M$ -51.13M
$ 13.17M$ 19.47M$ 15.22M$ 2.63M$ -31.00K
$ -142.83M$ 66.48M$ 12.06M$ -94.62M$ -51.16M
$ -143.75M$ 65.63M$ -6.68M$ -94.62M$ -51.16M
Per Share Metrics
Basic EPS$ -3.47$ 1.76$ -0.20$ -2.79$ -1.60
Diluted EPS$ -3.47$ 1.68$ -0.20$ -2.79$ -1.60
Weighted Average Shares Outstanding41.37M37.31M33.05M31.29M31.22M
Weighted Average Shares Outstanding (Diluted)41.37M39.00M33.05M31.29M31.22M

Currency in USD

Entrada Therapeutics Inc Earnings and Revenue History

-200M0200M400M-600 %-300 %0 %300 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin